• OPEN AN ACCOUNT
Indian Indices
Sensex
76,515.43 362.57
( 0.48%)
Global Indices
Nasdaq
53,423.66 -283.45
(-0.53%)
Dow Jones
7,737.34 -31.37
(-0.40%)
Hang Seng
65,002.68 788.20
(1.23%)
Nikkei 225
10,828.70 -2.82
(-0.03%)
Forex
USD-INR
94.48 -0.24
(-0.26%)
EUR-INR
109.71 0.00
(0.00%)
GBP-INR
127.63 -0.19
(-0.15%)
JPY-INR
0.60 0.01
(1.60%)

EQUITY - MARKET SCREENER

Ridhi Synthetics Ltd
Industry :  Construction
BSE Code
ISIN Demat
Book Value()
504365
INE07LK01010
430.5490849
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0.48
0.49
EPS(TTM)
Face Value()
Div & Yield %
8.48
10
0
 

Fredun Pharmaceuticals standalone net profit rises 56.58% in the March 2026 quarter
May 25,2026
Net profit of Fredun Pharmaceuticals rose 56.58% to Rs 11.07 crore in the quarter ended March 2026 as against Rs 7.07 crore during the previous quarter ended March 2025. Sales rose 27.18% to Rs 210.41 crore in the quarter ended March 2026 as against Rs 165.44 crore during the previous quarter ended March 2025.

For the full year,net profit rose 59.59% to Rs 33.21 crore in the year ended March 2026 as against Rs 20.81 crore during the previous year ended March 2025. Sales rose 40.21% to Rs 633.33 crore in the year ended March 2026 as against Rs 451.71 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales210.41165.44 27 633.33451.71 40
OPM %13.8510.54 -14.9712.20 -
PBDT14.659.29 58 55.5032.72 70
PBT11.548.04 44 47.5928.27 68
NP11.077.07 57 33.2120.81 60